A carregar...

Modulation of GITR for cancer immunotherapy

Modulation of co-inhibitory and co-stimulatory receptors of the immune system has become a promising new approach for immunotherapy of cancer. With the recent FDA approval of CTLA-4 blockade serving as an important proof of principal, many new targets are now being translated into the clinic. Precli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schaer, David A, Murphy, Judith T, Wolchok, Jedd D
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3413251/
https://ncbi.nlm.nih.gov/pubmed/22245556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2011.12.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!